All posts by Brian LM Cheng

G1 Therapeutics (GTHX) Price Targets/ Analysis Overview

G1 Therapeutics (GTHX) is a clinical stage pharmaceutical company based in Durham, NC. It is a company with several pipeline products in oncology focusing on modulating the activity of CDK4 and CDK6 cell cycle related enzymes in cancer patients.

It recently IPO in May 17, 2017 at $15/share and raise $105M from the IPO. The IPO was led by JPM and Cowen & Co. The capital from the IPO will be used to develop the 3 pipeline products, which $45M will be allocated to develop its frontrunner, trilaciclib in various cancer indications. Its current price is around $16-17/share.

Its current 12-months target prices are:

JP Morgan: $23.00 +35.3% (6/12/2017),

Needham & Co.: $34.00 +100% (6/12/2017) and

WedBush: $31.00 +82.4% (6/11/2017).

We have conducted further research analyses on the preclinical data – next page

博士学位工资比较(2017-2018) – 更新板

去了解每所美国大学的博士学位薪水进展情况,我们再次调查了美国顶尖大学的奖学金。

我们在今年USNews的大学名单中提取大部分的前15名大学。

入读商业的博士生普遍得到较高的津贴。例如,芝加哥大学商学院的博士生获得了每年4万美元,而同一所学校的化学/生物科学博士生只为31500美元。27%的薪酬差距并不足以说明部门之间的困难。这种差异也在哈佛大学看到。

我们比较了每个学校的津贴。我们根据在bankrate.com上找到的计算器提供的生活费用,将每个津贴调整为支付给芝加哥的津贴。我们发现:

上面列出的平均津贴是30061美元/年。

接下来,我们将这笔津贴列为由Pew Research提供的“你在美国中产阶级计算器”中。